BIO News and Press, Bio-Rad Laboratories Inc. Class A From 11/29/22

Eisai Announces Approval of Partial Change to Label for Dosage and Administration of Aricept for Treatment of Dementia with Lewy Bodies TOKYO, Nov 29, 2022 - (JCN Newswire) - Eisai Co., Ltd. announced that its application for a partial change to label for Aricept (donepezil hy...

Eisai to Present Latest Data on Perampanel at the 76th American Epilepsy Society (AES) Annual Meeting TOKYO, Nov 24, 2022 - (JCN Newswire) - Eisai Co., Ltd. announced today that the company will have a total of 34 poster presentations, including the latest data on its in-house...

Malaysian Genomics Sees Rise in Profit Margins for 1Q PETALING JAYA, Malaysia, Nov 23, 2022 - (ACN Newswire) - Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, today reported a revenue of RM3.81 million for the first quarter ended...

To Develop Japan's First Blood Biomarker-Based Diagnostic Workflow for Dementia Shimadzu, Eisai, Oita University, and Usuki City Medical Association Commence Joint Research TOKYO, Nov 22, 2022 - (JCN Newswire) - Shimadzu Corporation (Shimadzu), Eisai Co., Ltd. (Eisai), Oita Un...

Eisai to Present Full Findings from Lecanemab Confirmatory Phase 3 Clinical Trial (Clarity AD) and Other Alzheimer's Disease Research at The 15th Clinical Trials on Alzheimer's Disease (CTAD) Conference TOKYO, Nov 21, 2022 - (JCN Newswire) - Eisai Co., Ltd. will present the ef...

Metoject Subcutaneous Injection Syringe (Methotrexate) Launched In Japan For Rheumatoid Arthritis TOKYO, Nov 16, 2022 - (JCN Newswire) - Eisai Co., Ltd. and nippon medac Co., Ltd., a subsidiary of medac Gesellschaft fur klinische Spezialpraparate mbH announced today that they ...

InaVac gets emergency approval from BPOM Surabaya, East Java, Indonesia, Nov 14, 2022 - (ACN Newswire) - The Food and Drug Supervisory Agency (BPOM) has issued emergency use authorization (EUA) for InaVac, a COVID-19 vaccine developed by researchers from Airlangga University (...

Novotech Chairs BioCentury Summit Workshop on How to Build and Finance an East-West MRCT Strategy SYDNEY, AU, Nov 11, 2022 - (ACN Newswire) - Novotech, the leading Asia Pacific biotech specialist CRO, is sponsoring BioCentury-BayHelix East-West Summit 2022, and Novotech's Chie...

Eisai to Divest Rights for Muscle Relaxant Myonal, Vertigo, and Equilibrium Disturbance Treatment Merislon in Asia to DKSH TOKYO, Nov 7, 2022 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has entered into an agreement to divest its rights for muscle relaxant Myona...

Eisai's Sales Subsidiary Collaborates with Thai Life Insurance to Support Access to Treatments for Dementia, Including Alzheimer's Disease, in Thailand TOKYO, Nov 4, 2022 - (JCN Newswire) - Eisai Co., Ltd. announced today that its Thai sales subsidiary Eisai (Thailand) Marketi...